Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1169 | Nuclear receptors and Signal transduction | ICEECE2012

Effects of benzbromarone on serum CRP in patients with gout

Yamamoto T. , Sumida C. , Kurajoh M. , Shoji T. , Tsutsumi Z. , Koyama H. , Moriwaki Y.

Introduction: C-reactive protein (CRP), an acute reactant protein and member of the pentraxins family has a primitive defense function against exogenous organisms. Although its production is predominantly under the control of IL-6, IL-1 and tumor necrotic factor also contribute to hepatic synthesis and CRP secretion. CRP is mainly produced in the liver and possibly other tissues, such as atherosclerotic lesions. C-reactive protein (CRP) is associated with increased risk for ca...

ea0029p2 | Adrenal cortex | ICEECE2012

Pathophysiological significance of CYP11B2 immunohistochemical staining in primary aldosteronism

Nanba K. , Tsuiki M. , Sawai K. , Mukai K. , Nakao K. , Tamanaha T. , Usui T. , Tagami T. , Okuno H. , Yamamoto T. , Shimatsu A. , Naruse M.

Background: Although primary aldosteronism (PA) is the common cause of hypertension subjected to surgery, methods of pathological confirmation of aldosterone overproduction have not been established. Aim of the study was to investigate immunohistochemically the expression of CYP11B2 in the adrenal tissue of PA.Methods: Twenty five patients with PA including 20 patients with aldosterone-producing adenoma (APA) and 5 patients without APA (non-APA) were stu...

ea0029p1837 | Thyroid cancer | ICEECE2012

A novel tandem germline RET mutations on the same allele in a patient with MEN 2B

Nakao K. , Usui T. , Ikeda M. , Mori Y. , Kawashima S. , Nanba K. , Tamanaha T. , Tagami T. , Naruse M. , Yamamoto T. , Shimatsu A.

Multiple endocrine neoplasia type2 (MEN 2) (OMIM 171400) is an autosomal dominant inherited cancer syndrome caused by activating mutations in the RET proto-oncogene. MEN 2 is classified into three subtypes: MEN 2A, MEN 2B and familial medullary thyroid carcinoma(FMTC). MEN 2B accounts for 5–10% of MEN2 cases. More than 95% of MEN 2B patients carry M918T mutation of RET, and 2–3% harbor A883F mutation. There has been three reports of cases with MEN 2B phenotype caused...